Optimizing the Freezing of Mouse Lymph Nodes, Thymus, and Bone Marrow for Flow Cytometry

Introduction

In flow cytometry workflows, the timely arrival of antibodies and reagents is crucial for accurate and reliable results. However, unforeseen delays can necessitate the preservation of biological samples for later analysis. Freezing mouse inguinal lymph nodes, thymus, and bone marrow tissues is a viable strategy to mitigate such delays. This comprehensive guide explores the impact of freezing on flow cytometry results, evaluates the feasibility of cutting and freezing tissue samples, and provides detailed protocols for cryopreservation to ensure minimal compromise to cell viability and marker integrity.

Impact of Freezing on Flow Cytometry Results

Cell Viability and Marker Expression

Freezing biological samples can influence cell viability and alter the expression of surface and intracellular markers, which are critical parameters in flow cytometry. Proper cryopreservation techniques are essential to maintain high cell viability and preserve marker integrity. Studies have demonstrated that while freezing can cause some loss in cell viability, the use of effective cryoprotectants like dimethyl sulfoxide (DMSO) can significantly mitigate this effect. Specifically, the proportions of key lymphocyte subsets, including T-helper and T-suppressor cells, remain largely consistent between fresh and frozen samples when appropriate freezing protocols are employed.

Effects on Specific Tissue Types

The resilience of different tissues to freezing varies. Bone marrow cells, particularly hematopoietic stem cells, exhibit higher tolerance to cryopreservation compared to lymph nodes and thymus tissues. This disparity arises from the unique structural and cellular compositions of these tissues. Bone marrow-derived cells are frequently subjected to cryopreservation in various research and clinical settings, underscoring their robustness. Conversely, lymph node and thymus cells may experience a relatively faster decline in viability post-freezing, necessitating meticulous adherence to cryopreservation protocols to preserve their functional and phenotypic characteristics.

Feasibility of Cutting and Freezing Tissue Samples

Tissue Preparation and Fragmentation

Cutting tissues into smaller, manageable pieces before freezing is not only feasible but also recommended to enhance cryoprotectant penetration and ensure uniform freezing. Fragmenting the samples into approximately 1–2 mm³ pieces facilitates even distribution of the cryopreservation solution, thereby maintaining consistent cell viability across the entire sample. This approach minimizes the formation of ice crystals, which can cause cellular damage and compromise the integrity of cell surface markers.

Controlled Freezing Techniques

Employing a controlled-rate freezing method is crucial for optimal preservation. This involves gradually lowering the temperature at a rate of approximately -1°C per minute until the samples reach -80°C, followed by storage in liquid nitrogen at -196°C for long-term preservation. The use of specialized freezing containers, such as isopropanol-based freezing units (e.g., Mr. Frosty), can facilitate this controlled cooling process without the need for sophisticated equipment.

Creating Single-Cell Suspensions

For enhanced preservation of cell integrity and marker expression, converting tissue fragments into single-cell suspensions prior to freezing is advisable. This process involves mechanically dissociating the tissues, filtering to remove debris and cell clumps, and accurately counting viable cells. Single-cell suspensions allow for more uniform exposure to cryoprotectants and reduce the risk of cellular aggregation, which can impede effective freezing and subsequent flow cytometric analysis.

Cryopreservation Protocols

Preparation of Cryopreservation Solution

An effective cryopreservation solution is pivotal for maintaining cell viability during freezing and thawing. A commonly recommended composition includes:

• 90% Fetal Bovine Serum (FBS) or complete cell culture medium
• 10% Dimethyl Sulfoxide (DMSO) as a cryoprotectant

For example, to prepare the solution:

1. Mix 9 parts FBS with 1 part DMSO in a sterile environment.
2. Pre-chill the solution to 4°C to minimize cell stress during addition.

Freezing Procedure

1. Cell Suspension Preparation: Resuspend the dissociated single cells in cold complete medium before introducing the cryopreservation solution.
2. Addition of Cryopreservation Solution: Slowly add the pre-cooled cryopreservation solution to the cell suspension dropwise while gently swirling to ensure uniform mixing and prevent osmotic shock.
3. Aliquoting: Distribute the mixed cells into pre-labeled cryovials, aliquoting approximately 1–1.5 mL per vial to facilitate efficient freezing and subsequent thawing.
4. Controlled Freezing: Place the cryovials in a controlled-rate freezing container to achieve a gradual temperature reduction of approximately -1°C per minute until reaching -80°C.
5. Long-Term Storage: After the initial freezing phase, transfer the cryovials to liquid nitrogen storage for preservation at ultra-low temperatures.

Critical Considerations During Freezing

• Consistent Cryoprotectant Exposure: Ensure that all tissue fragments or cells are fully immersed in the cryopreservation solution to provide uniform protection against ice crystal formation.
• Avoiding Gradients in Cryoprotectant Concentration: Do not employ a gradient or layering approach when adding cryopreservation solutions, as this can lead to inconsistent cryoprotection and variable cell viability.
• Minimizing Freeze-Thaw Cycles: Limit the number of times samples are frozen and thawed to prevent cumulative cellular damage.
• Labeling: Clearly label all cryovials with pertinent information such as tissue type, date of freezing, cell concentration, and any experimental treatments to ensure traceability and organization.

Thawing and Recovery

Thawing Procedure

1. Remove cryovials from liquid nitrogen storage and immerse them directly in a 37°C water bath.
2. Gently agitate the vials until only a small ice crystal remains, typically within 1–2 minutes, to prevent cellular shock.
3. Immediately transfer the thawed cells to a warm culture medium to dilute the DMSO, which can be toxic at higher concentrations.
4. Perform a centrifugation step to remove residual cryoprotectants and resuspend the cells in fresh buffer for flow cytometry staining.

Post-Thaw Considerations

• Viability Assessment: Use viability dyes such as 7-AAD or Propidium Iodide (PI) during flow cytometry to discriminate live cells from dead ones, as thawed samples may have increased cellular debris and non-viable cells.
• Marker Validation: Validate the stability and expression levels of specific cell surface and intracellular markers post-thawing by comparing them with fresh samples to ensure data accuracy.
• Sample Optimization: Conduct pilot experiments with a subset of samples to optimize staining protocols and gating strategies, accounting for any alterations induced by the freezing process.

Best Practices and Recommendations

Pilot Testing

Before committing to freezing all samples, perform pilot tests to evaluate the efficacy of the cryopreservation protocol on your specific tissue types. This step is vital to identify any potential issues with cell viability or marker expression that may arise due to freezing and thawing.

Use of High-Quality Reagents

Utilize high-purity cryoprotectants and media components to enhance cell survival rates. The quality of FBS and DMSO directly influences the outcome of the cryopreservation process.

Consistent Handling Procedures

Maintain consistency in sample handling from tissue dissociation to freezing. Variations in processing times, temperatures, and reagent concentrations can lead to inconsistencies in flow cytometry results.

Conclusion

Freezing mouse inguinal lymph nodes, thymus, and bone marrow tissues is a practical solution to accommodate delays in antibody availability for flow cytometry. By adhering to meticulously developed cryopreservation protocols—emphasizing controlled-rate freezing, appropriate cryoprotectant use, and careful tissue preparation—researchers can preserve cell viability and marker integrity effectively. Cutting tissues into small fragments or creating single-cell suspensions prior to freezing enhances cryoprotection and ensures uniform preservation across samples. Post-thaw validation and optimization are essential steps to guarantee the reliability and accuracy of flow cytometry data. Implementing these best practices will facilitate seamless integration of preserved samples into your experimental workflow, thereby maintaining the integrity and reproducibility of your research outcomes.

For additional guidance on cryopreservation and flow cytometry protocols, refer to the detailed guidelines available in immunology research literature, such as the comprehensive guidelines published by Wiley [here](https://onlinelibrary.wiley.com/doi/10.1002/eji.202170126){:target="_blank"}.